Header cover image

Chinese Healthcare Buy the Dip

UPDATED Jul 05, 2022

Companies which may present a buying opportunity after a dip in share price.

11 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
300642TellgenCN„23.273.1%-47.2%CN„3.8bCN„33.90PE26.6xE29.2%1.1%
688329Suzhou Iron TechnologyLTDCN„31.44-3.3%-60.7%CN„2.4bn/aPE27.2xE30.7%1.6%
600535Tasly Pharmaceutical GroupCN„10.55-0.5%-25.9%CN„15.7bCN„11.44PE10.6xE11.6%3.1%
688575Shenzhen YHLO BiotechCN„21.374.1%-27.5%CN„12.1bn/aPE17.9xE4.6%1.3%
2432Andon HealthCN„61.171.1%736.8%CN„27.9bn/aPE1.8xn/a1.1%
300981Zhonghong Pulin Medical ProductsCN„25.571.4%-57.0%CN„7.7bn/aPE7.7xn/a13.0%
2932Wuhan Easy Diagnosis BiomedicineLtdCN„71.684.5%64.8%CN„11.2bn/aPE4.5xn/a4.2%
688606Hangzhou Alltest BiotechCN„122.821.3%-15.3%CN„6.6bn/aPE4xn/a3.3%
688075Assure Tech (Hangzhou)CN„118.38-1.2%n/aCN„10.7bn/aPE3.2xn/a2.2%
301093Jiangsu Hualan New Pharmaceutical MaterialCN„34.101.2%n/aCN„4.6bn/aPE22.3xn/a2.1%
688399Jiangsu Bioperfectus TechnologiesCN„119.754.0%-22.8%CN„7.0bn/aPE4.9xn/a8.4%
Page 1 of 1